Table 1 Characteristics of the disease in the 10 patients with Parkinson's disease.

Characteristic		Patient
		1		2		3		4	5	6	7	8		9		10
Duration of disease (years)	18		10		10		29		13	19	6	12	8		12
Hoehn–Yahr stage	III		III		III		IV		III	III	III	IV	III		IV
UPDRS part III in the on state	30		19		28		33		22	24	31	35	25		31
UPDRS part III in the off state	45		57		40		65		38	NA	40	48	44		44
Levodopa (mg/day); duration (years)	1750; 14		1000; 8		1000; 8		2200; 25		850; 12	800; 18	400; 5	1350; 10	1200; 8		600; 10
Other drugs, mg/day	Bromocriptin 15		Pergolide 6; Amantadine 300		Bromocriptin 40; Amantadine 300		Pergolide 3; Amantadine 300		Piribedil 100; Segiline 10	Bromocriptin 50; Segiline 10	None	Trihexipphenidyle 4	Lisuride 0.8; Segiline 10		Bromocriptin 15; Trihexipphenidyle 10; Tolcapone 600

UPDRS, Unified Parkinson's Disease Rating Scale.